A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Routine use of tolvaptan in clinical practice may slow eGFR decline for patients with autosomal dominant polycystic kidney ...

Expert Rev Cardiovasc Ther. 2008;6(5):601-608. The first Phase III clinical trial to study tolvaptan was the Study of Ascending Levels of Tolvaptan in Hyponatremia (SALT)-1/-2, which consisted of ...

Pituitary hormones were normal and urinary sodium and urinary and plasma osmolality supported the diagnosis of SIAD. Therefore, tolvaptan 7.5 mg daily was started, with sustained normalization of ...